Literature DB >> 7789337

Combined magnetic fields increase insulin-like growth factor-II in TE-85 human osteosarcoma bone cell cultures.

R J Fitzsimmons1, J T Ryaby, S Mohan, F P Magee, D J Baylink.   

Abstract

In vitro exposure to low-energy, combined magnetic fields (CMF) increased the release of insulin-like growth factor (IGF)-II from human TE-85 osteosarcoma cells. Short-term CMF exposure of only 10 min increased IGF-II levels in conditioned medium 1 h post CMF exposure. IGF-II levels were measured with a radioreceptor assay using H-35 cells that contain abundant IGF-II but not IGF-I receptors. This assay also uses a recently validated BioGel P-10 acid gel filtration method to remove IGF binding protein before quantitation of either IGF-I or IGF-II. In addition to an increase in IGF-II levels, DNA synthesis, as an index of cell proliferation, was increased during the 24-h period post CMF exposure. A monoclonal antibody against IGF-II blocked the increase in cell proliferation following CMF exposure, whereas a control monoclonal antibody against osteocalcin did not attenuate the mitogenic action of CMF exposure. The effect of CMF exposure to increase both cell proliferation and IGF-II was cell-density dependent with greater stimulation by CMF observed at lower densities. Together, these data are consistent with the hypothesis that CMF exposure stimulates release/production of IGF-II from bone cells and that increased IGF-II then promotes an increase in cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789337     DOI: 10.1210/endo.136.7.7789337

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Electrical stimulation therapies for spinal fusions: current concepts.

Authors:  Jean C Gan; Paul A Glazer
Journal:  Eur Spine J       Date:  2006-04-08       Impact factor: 3.134

Review 2.  Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 levels in aging and age-associated diseases.

Authors:  S Mohan; D J Baylink
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 3.  Pulsed electromagnetic fields: promising treatment for osteoporosis.

Authors:  T Wang; L Yang; J Jiang; Y Liu; Z Fan; C Zhong; C He
Journal:  Osteoporos Int       Date:  2019-01-02       Impact factor: 4.507

4.  Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study.

Authors:  Justus H W Jansen; Olav P van der Jagt; Bas J Punt; Jan A N Verhaar; Johannes P T M van Leeuwen; Harrie Weinans; Holger Jahr
Journal:  BMC Musculoskelet Disord       Date:  2010-08-23       Impact factor: 2.362

5.  Electrical stimulation in bone healing: critical analysis by evaluating levels of evidence.

Authors:  Michelle Griffin; Ardeshir Bayat
Journal:  Eplasty       Date:  2011-07-26

6.  Systemic treatment with pulsed electromagnetic fields do not affect bone microarchitecture in osteoporotic rats.

Authors:  Olav P van der Jagt; Jacqueline C van der Linden; Jan H Waarsing; Jan A N Verhaar; Harrie Weinans
Journal:  Int Orthop       Date:  2012-01-17       Impact factor: 3.075

7.  Combined magnetic fields provide robust coverage for interbody and posterolateral lumbar spinal fusion sites.

Authors:  Timothy Wade Stippick; Michael Richard Sheller
Journal:  Med Biol Eng Comput       Date:  2015-06-05       Impact factor: 2.602

Review 8.  Bone tissue regeneration: biology, strategies and interface studies.

Authors:  Mojtaba Ansari
Journal:  Prog Biomater       Date:  2019-11-25

9.  Effects of electromagnetic fields on osteogenesis of human alveolar bone-derived mesenchymal stem cells.

Authors:  KiTaek Lim; Jin Hexiu; Jangho Kim; Hoon Seonwoo; Woo Jae Cho; Pill-Hoon Choung; Jong Hoon Chung
Journal:  Biomed Res Int       Date:  2013-06-19       Impact factor: 3.411

10.  Electromagnetic fields do not affect bone micro-architecture in osteoporotic rats.

Authors:  O P van der Jagt; J C van der Linden; J H Waarsing; J A N Verhaar; H Weinans
Journal:  Bone Joint Res       Date:  2014-07       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.